Homo sapiens
NRAS mutant melanoma cell line IPC298 treated with CDK4/6i (Palbociclib) 1?M and MEKi (Bnimetinib) 16 nM for 33 days
INSDC center name
Department of Life Science and Medecine
Submitter Id
A5_S4/
batch
batch_1
cell_line
IPC298
cell_type
Melanoma
common name
human
inhibitors
CDK4/6i (Palbociclib) 1?M, MEKi (Bnimetinib) 16 nM
sample name
A5_S4/
scientific_name
Homo sapiens
sex
female
time of treatment
Day33